Low-molecular-weight heparin

This publication has 39 references indexed in Scilit:

• Pharmacological modulation of fibrinolysis by antithrombotic and cardiovascular drugs
  Progress in Cardiovascular Diseases, 1992
• A Randomised Trial of Subcutaneous Low Molecular Weight Heparin (CY 216) Compared with lntravenous Unfractionated Heparin in the Treatment of Deep Vein Thrombosis
  Thrombosis and Haemostasis, 1991
• Prevention of deep vein thrombosis by low-molecular-weight heparin and dihydroergotamine in patients undergoing total hip replacement
  Thrombosis Research, 1991
• Thromboembolieprophylaxe mit niedermolekularem Heparin in der Abdominalchirurgie
  Deutsche Medizinische Wochenschrift (1946), 1989
• Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery
  British Journal of Surgery, 1988
• A Randomized Double-Blind Study Between a Low Molecular Weight Heparin Kabi 2165 and Standard Heparin in the Prevention of Deep Vein Thrombosis in General Surgery
  Thrombosis and Haemostasis, 1988
• Low molecular weight heparin (KABI 2165, Fragmin): pharmacokinetics after intravenous and subcutaneous administration in human volunteers
  Thrombosis Research, 1986
• Low molecular weight heparin once daily compared with conventional low-dose heparin twice daily. A prospective double-blind multicentre trial on prevention of postoperative thrombosis
  British Journal of Surgery, 1986
• Anticoagulant Activities of High and Low Molecular Weight Heparin Fractions
  British Journal of Haematology, 1979
• LOW DOSES OF SUBCUTANEOUS HEPARIN IN THE PREVENTION OF DEEP VEIN THROMBOSIS AFTER GYNAECOLOGICAL SURGERY
  BJOG: An International Journal of Obstetrics and Gynaecology, 1973